Comorbid cerebrovascular and neurodegenerative burden in mild behavioural impairment and their impact on clinical trajectory
Open Access
- 13 March 2025
- journal article
- research article
- Published by Cambridge University Press (CUP) in Acta Neuropsychiatrica
- Vol. 37, 1-22
Abstract
Aim: Mild behavioural impairment (MBI) is a neurobehavioral prodrome to dementia with multiple phenotypic characteristics. To investigate the complex neurobiological substrate underlying MBI, we evaluated its association with a composite magnetic resonance imaging (MRI)-based measure of concomitant cerebrovascular disease (CeVD) and neurodegeneration; and the interaction effects of MBI and MRI scores on cognitive and clinical trajectory. Methods: 253 dementia-free participants (mean age = 71.9, follow-up period = 49.89 months) from 2 memory clinics were included in this study. 37 (14.6%) participants met clinical diagnostic criteria for MBI, ascertained by repeated neuropsychiatric inventory assessments. MRI scores were computed using a validated weighted sum of white matter hyperintensities volume, presence of infarct, hippocampal volume, and cortical thickness of known Alzheimer’s disease-associated regions. Clinical and cognitive outcomes were evaluated annually using the Clinical Dementia Rating sum-of-boxes (CDR-SB) and standardised global cognitive scores of a comprehensive neuropsychological battery respectively. Results: Lower MRI scores, indicating greater burden of comorbid CeVD and neurodegeneration, yielded a 3.8-fold likelihood of MBI compared to 1.5-fold with larger WMH volume or lower cortical thickness individually. Interaction analyses showed that MBI participants with low MRI scores had greater increase in CDR-SB (B = 0.05, SE = 0.01, p < 0.001) over time. All models involving the composite MRI measure yielded a better fit compared to reduced models with either pathology alone. Conclusion: MBI is associated with a composite MRI measure that reflects mixed pathologies of dementia and their co-evaluation may improve risk profiling and identification of memory clinic patients without dementia who are at the highest risk of experiencing clinical decline.Keywords
This publication has 38 references indexed in Scilit:
- Interactions of comorbid neuropsychiatric subsyndromes with neurodegenerative and cerebrovascular pathologies on cognitionNeurobiology of Aging, 2022
- White matter hyperintensities and mild behavioral impairment: Findings from the MEMENTO cohort studyCerebral Circulation - Cognition and Behavior, 2021
- Mild behavioral impairment is associated with β‐amyloid but not tau or neurodegeneration in cognitively intact elderly individualsAlzheimer's & Dementia, 2020
- Mild Behavioral Impairment as a Marker of Cognitive Decline in Cognitively Normal Older AdultsThe American Journal of Geriatric Psychiatry, 2019
- Time course of neuropsychiatric symptoms and cognitive diagnosis in National Alzheimer's Coordinating Centers volunteersAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2019
- Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesisAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2017
- Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairmentAlzheimer's & Dementia, 2015
- Challenges of multimorbidity of the aging brain: a critical updateJournal of Neural Transmission, 2014
- Neuropathologic Basis of Age-Associated Brain AtrophyJAMA Neurology, 2013
- An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interestNeuroImage, 2006